Premature ovarian insufficiency: the context of long-term effects
暂无分享,去创建一个
K. Czajkowski | R. Smolarczyk | B. Męczekalski | K. Katulski | M. Grymowicz | A. Czyżyk | A. Podfigurna-Stopa
[1] F. Brancati,et al. Characterization of endocrine features and genotype–phenotypes correlations in blepharophimosis–ptosis–epicanthus inversus syndrome type 1 , 2016, Journal of Endocrinological Investigation.
[2] Jianfeng Xu,et al. Risks associated with premature ovarian failure in Han Chinese women. , 2015, Reproductive biomedicine online.
[3] D. Galliano,et al. Spanish consensus on premature menopause. , 2015, Maturitas.
[4] P. Giraldo,et al. Vaginal epithelium and microflora characteristics in women with premature ovarian failure under hormone therapy compared to healthy women , 2015, Archives of Gynecology and Obstetrics.
[5] C. Orlandini,et al. Premature ovarian insufficiency: from pathogenesis to clinical management , 2015, Journal of Endocrinological Investigation.
[6] D. Balzi,et al. Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[7] H. Critchley,et al. Sex hormone replacement in ovarian failure - new treatment concepts. , 2015, Best practice & research. Clinical endocrinology & metabolism.
[8] D. Portman,et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society , 2014, Climacteric : the journal of the International Menopause Society.
[9] G. Yeşil,et al. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. , 2014, Maturitas.
[10] D. Portman,et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society , 2014, Menopause.
[11] P. Giraldo,et al. Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health , 2014, Climacteric : the journal of the International Menopause Society.
[12] P. Bruzzi,et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. , 2014, Cancer treatment reviews.
[13] H. Teede,et al. Symptoms, health behavior and understanding of menopause therapy in women with premature menopause , 2014, Climacteric : the journal of the International Menopause Society.
[14] B. Kong,et al. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. , 2014, International journal of oncology.
[15] X. Shu,et al. Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese Women , 2014, PloS one.
[16] S. Orešković,et al. Fertility after breast cancer treatment. , 2014, European journal of obstetrics, gynecology, and reproductive biology.
[17] D. Bennett,et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women , 2014, Neurology.
[18] R. Bove. Autoimmune diseases and reproductive aging. , 2013, Clinical immunology.
[19] N. Naredi,et al. Can hormone replacement therapy prior to oocyte donation cycle in women with premature ovarian failure improve pregnancy rate? , 2013, Medical journal, Armed Forces India.
[20] A. Oto,et al. The cardiovascular effects of premature ovarian failure. , 2013, International journal of cardiology.
[21] M. Kulaksızoğlu,et al. Risk Factors for Diabetes Mellitus in Women with Primary Ovarian Insufficiency , 2013, Biological Trace Element Research.
[22] M. A. Checa,et al. Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[23] P. Spritzer,et al. Cardiovascular autonomic dysfunction in primary ovarian insufficiency: clinical and experimental evidence. , 2013, American journal of translational research.
[24] Management of women with endometriosis Guideline of the European Society of Human Reproduction and Embryology , 2013 .
[25] B. Pamuk,et al. Serum lipid levels in women with premature ovarian failure , 2012, Menopause.
[26] K. Oktay,et al. Options on fertility preservation in female cancer patients. , 2012, Cancer treatment reviews.
[27] J. Golmard,et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. , 2011, The Journal of clinical endocrinology and metabolism.
[28] P. Schnatz. The 2010 North American Menopause Society position statement: Updates on screening, prevention and management of postmenopausal osteoporosis. , 2011, Connecticut medicine.
[29] A. Hershlag,et al. Part 2: Ovarian failure in adolescent cancer survivors should be treated. , 2011, Journal of pediatric and adolescent gynecology.
[30] J. Fish. Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? , 2011, Journal of pediatric and adolescent gynecology.
[31] C. Benetti-Pinto,et al. Sexual function of women with premature ovarian failure , 2011, Menopause.
[32] D. Rubinow,et al. Depression in women with spontaneous 46, XX primary ovarian insufficiency. , 2010, The Journal of clinical endocrinology and metabolism.
[33] L. Galluzzo,et al. What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[34] K. Schenck-Gustafsson,et al. EMAS position statement: Managing women with premature ovarian failure. , 2010, Maturitas.
[35] A. Genazzani,et al. Hypoestrogenism in young women and its influence on bone mass density , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[36] B. Urman,et al. Options of Fertility Preservation in Female Cancer Patients , 2010, Obstetrical & gynecological survey.
[37] L. Kessing,et al. Hysterectomy, Oophorectomy and Risk of Dementia: A Nationwide Historical Cohort Study , 2010, Dementia and Geriatric Cognitive Disorders.
[38] W. Rocca,et al. Premature menopause or early menopause: long-term health consequences. , 2010, Maturitas.
[39] L. Nelson. Clinical practice. Primary ovarian insufficiency. , 2009, The New England journal of medicine.
[40] B. Vollenhoven,et al. In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? , 2009, Journal of Assisted Reproduction and Genetics.
[41] J. Troendle,et al. Bone mineral density in estrogen-deficient young women. , 2009, The Journal of clinical endocrinology and metabolism.
[42] K. Devarajan,et al. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. , 2009, Gynecologic oncology.
[43] Demetrius M Maraganore,et al. Long-Term Effects of Bilateral Oophorectomy on Brain Aging: Unanswered Questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging , 2009, Women's health.
[44] A. Pinto-Neto,et al. Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure , 2009, Archives of Gynecology and Obstetrics.
[45] M. Eijkemans,et al. Lipid profile of women with premature ovarian failure , 2008, Menopause.
[46] C. Lambalk,et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure , 2008, Menopause.
[47] J. Leach,et al. Guideline Development Group , 2008 .
[48] Sue-Kyung Park,et al. Premenopausal factors influencing premature ovarian failure and early menopause. , 2007, Maturitas.
[49] Elizabeth W Karlson,et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. , 2007, Arthritis and rheumatism.
[50] R. Goswami,et al. Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. , 2006, The Journal of clinical endocrinology and metabolism.
[51] J. Ross,et al. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. , 2006, JAMA.
[52] L. Dennerstein,et al. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. , 2006, The journal of sexual medicine.
[53] N. Keiding,et al. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. , 2006, Maturitas.
[54] E. Calle,et al. Age at natural menopause and cause-specific mortality. , 2005, American journal of epidemiology.
[55] M. Merino,et al. Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. , 2005, Fertility and sterility.
[56] S. Batıoğlu,et al. Bone loss in young women with premature ovarian failure , 2005, Archives of Gynecology and Obstetrics.
[57] L. Nelson,et al. An update: spontaneous premature ovarian failure is not an early menopause. , 2005, Fertility and sterility.
[58] J. Olsen,et al. Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study , 2005, British Journal of Cancer.
[59] G. Chrousos,et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[60] Ivar Heuch,et al. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. , 2003, American journal of epidemiology.
[61] D. V. D. Voort,et al. Early menopause: increased fracture risk at older age , 2003, Osteoporosis International.
[62] L. Nelson,et al. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. , 2002, Human reproduction.
[63] E. Khedr,et al. Effect of Surgical Menopause on Cognitive Functions , 2002, Dementia and Geriatric Cognitive Disorders.
[64] D. Schoenfeld,et al. Identification of premature ovarian failure patients with underlying autoimmunity. , 2000, Journal of women's health & gender-based medicine.
[65] B. Jacobsen,et al. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. , 1999, Journal of clinical epidemiology.
[66] E. Sinforiani,et al. Memory Functioning at Menopause: Impact of Age in Ovariectomized Women , 1999, Gynecologic and Obstetric Investigation.
[67] L. Nelson,et al. Routine Endocrine Screening for Patients With Karyotypically Normal Spontaneous Premature Ovarian Failure , 1997, Obstetrics and gynecology.
[68] M. Boscaro,et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.
[69] M. Boscaro,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society I. Adrenal Cortex and Steroid 21-Hydroxylase Autoantibodies in Adult Patients with Organ-Specific Autoimmune Diseases: Markers of Low Progression , 2022 .
[70] M. Sauer,et al. Urodynamic Changes Following Hormonal Replacement Therapy in Women With Premature Ovarian Failure , 1989, Obstetrics and gynecology.
[71] J. Annegers,et al. Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.
[72] F. Albright,et al. A SYNDROME CHARACTERIZED BY PRIMARY OVARIAN INSUFFICIENCY AND DECREASED STATURE: Report of 11 Cases With a Digression on Hormonal Control of Axillary and Pubic Hair , 1942 .
[73] F. Albright,et al. POSTMENOPAUSAL OSTEOPOROSIS: ITS CLINICAL FEATURES , 1941 .